research Prevalence of Telogen Effluvium in Egyptian Women with Post-Covid 19 Viral Infection.
COVID-19 infection is linked to temporary hair loss in Egyptian women.
Search
for
Sort by
Research
360-390 / 1000+ results
research A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation
COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.
research Increase in Google Trends Regarding Telogen Effluvium Due To COVID-19
Public interest in hair loss increased during the COVID-19 pandemic.
research Thiol/disulfide homeostasis in patients with telogen effluvium: is oxidative stress important in the pathogenesis of telogen effluvium?
Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.
research Study of diffuse alopecia in females.
Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.
research Retrospective Review of 2851 Female Patients With Telogen Effluvium: A Single‐Center Experience
Ferritin and vitamin B12 deficiencies are common causes of hair loss in women aged 18-45.
research Anagen effluvium
Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.
research A Severe Case of Diffuse Telogen Effluvium Status Post Endoscopic Repair of Functional Brow Ptosis
A patient's hair loss after a browlift surgery improved on its own over 8 months.
research Fenómeno infrecuente la co-localización de alopecia frontal fibrosante y vitiligo en un varón. Informe de un caso
A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.
research Telogen effluvium associated with COVID‐19 infection
COVID-19 may cause hair loss due to infection stress or treatments.
research Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications
ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.
research Low-Dose Oral Minoxidil as Treatment for COVID-19–Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients
research Deflúvio Telogénico Crónico
The document's conclusion cannot be summarized because the content is not accessible or understandable.
research Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience
Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.
research Non-Scarring Alopecia in Women Presenting with Hair Loss: Clinical Features and Influencing Factors
Telogen effluvium is the most common hair loss in women, often linked to low iron, while tight hairstyles and headscarves increase traction alopecia risk.
research A Study of the Clinical Patterns of Hair Loss in Female Patients
Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
research Headband Alopecia
Infant hair loss is usually temporary and grows back without treatment.
research Letter: Telogen effluvium secondary to starvation diet
Starvation diets can cause significant hair loss.
research A Clinical Study of Prevalence of Telogen Effluvium after Childbirth
Hair loss after childbirth is more common in women who have had multiple births, cesarean deliveries, significant weight gain, and full-term pregnancies.
research Retrospective Evaluation of Patients with The Diagnosis of Telogen Effluvium
Many people with hair loss had low iron and ferritin levels.
research Diseases on Hair Follicles Leading to Hair Loss Part I: Nonscarring Alopecias
Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.
research Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned?
Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.
research The role of anemia and vitamin D levels in acute and chronic telogen effluvium
Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.
research Telogen Effluvium as a complication of scalp reconstruction with tissue expander: a case report.
A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.
research Diffuse hair loss in women.
Many women's hair loss is due to health issues, medication, nutrition, or stress.
research Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis
CTE and FPHL are different hair loss types with unique causes.
research Crash dieting associated with telogen effluvium.
Crash dieting can cause hair loss.
research Analysis of Risk Factors for Posttransplant Telogen Effluvium in Hair Transplantation Surgery: A Prospective Study
Older age, certain hair loss conditions, and specific chemical levels increase the risk of hair loss after a transplant.
research Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review
Hair loss from weight-loss treatments is usually temporary and reversible.
research Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
COVID-19 patients may experience hair loss, but it's not linked to their age or sex.